Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.

Authors :: Sarkozy C
Michot JM
Quivoron C
Camara-Clayette V
Danu A
Lazarovici J
El-Dakdouki Y
Saleh K
Ghez D
Rossignol J
Baldini C
Arfi-Rouche J
Romano-Martin P
Tselikas L
Varga A
Gazzah A
Hollebecque A
Lacroix L
Bahleda R
Lecourt H
Vergé V
Rahali W
Cotteret S
Soria JC
Dartigues P
Massard C
Ribrag V
Source :: American journal of hematology [Am J Hematol] 2021 Oct 01; Vol. 96 (10), pp. E376-E379. Date of Electronic Publication: 2021 Jul 10.
Publication Year :: 2021

Subjects :: Adult
Aged
Aged, 80 and over
Disease Management
Humans
Lymphoma, Large B-Cell, Diffuse therapy
Middle Aged
Molecular Targeted Therapy
Mutation
Neoplasm Recurrence, Local therapy
Precision Medicine
Therapies, Investigational
Lymphoma, Large B-Cell, Diffuse genetics
Neoplasm Recurrence, Local genetics

Full Text Access

Tools